Logo image of TRT

TRIO-TECH INTERNATIONAL (TRT) Stock Fundamental Analysis

NYSEARCA:TRT - NYSE Arca - US8967122057 - Common Stock - Currency: USD

6.4  +0.18 (+2.89%)

Fundamental Rating

4

Overall TRT gets a fundamental rating of 4 out of 10. We evaluated TRT against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. TRT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. TRT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

TRT had positive earnings in the past year.
TRT had a positive operating cash flow in the past year.
TRT had positive earnings in 4 of the past 5 years.
In the past 5 years TRT always reported a positive cash flow from operatings.
TRT Yearly Net Income VS EBIT VS OCF VS FCFTRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

TRT has a Return On Assets (1.47%) which is in line with its industry peers.
With a Return On Equity value of 1.83%, TRT perfoms like the industry average, outperforming 49.07% of the companies in the same industry.
TRT's Return On Invested Capital of 1.03% is in line compared to the rest of the industry. TRT outperforms 47.22% of its industry peers.
The Average Return On Invested Capital over the past 3 years for TRT is significantly below the industry average of 11.63%.
Industry RankSector Rank
ROA 1.47%
ROE 1.83%
ROIC 1.03%
ROA(3y)3.88%
ROA(5y)2.51%
ROE(3y)5.73%
ROE(5y)3.71%
ROIC(3y)4.2%
ROIC(5y)N/A
TRT Yearly ROA, ROE, ROICTRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

1.3 Margins

The Profit Margin of TRT (1.51%) is comparable to the rest of the industry.
TRT's Profit Margin has declined in the last couple of years.
TRT has a Operating Margin (1.23%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of TRT has grown nicely.
The Gross Margin of TRT (25.75%) is worse than 72.22% of its industry peers.
In the last couple of years the Gross Margin of TRT has grown nicely.
Industry RankSector Rank
OM 1.23%
PM (TTM) 1.51%
GM 25.75%
OM growth 3YN/A
OM growth 5Y6.23%
PM growth 3YN/A
PM growth 5Y-8.9%
GM growth 3Y2.49%
GM growth 5Y2.07%
TRT Yearly Profit, Operating, Gross MarginsTRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

7

2. Health

2.1 Basic Checks

TRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
TRT has more shares outstanding than it did 1 year ago.
TRT has more shares outstanding than it did 5 years ago.
TRT has a better debt/assets ratio than last year.
TRT Yearly Shares OutstandingTRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
TRT Yearly Total Debt VS Total AssetsTRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

TRT has an Altman-Z score of 4.15. This indicates that TRT is financially healthy and has little risk of bankruptcy at the moment.
TRT has a Altman-Z score (4.15) which is comparable to the rest of the industry.
The Debt to FCF ratio of TRT is 0.93, which is an excellent value as it means it would take TRT, only 0.93 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.93, TRT is in the better half of the industry, outperforming 79.63% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that TRT is not too dependend on debt financing.
The Debt to Equity ratio of TRT (0.02) is better than 61.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.93
Altman-Z 4.15
ROIC/WACC0.09
WACC11.44%
TRT Yearly LT Debt VS Equity VS FCFTRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 4.54 indicates that TRT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.54, TRT is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
TRT has a Quick Ratio of 4.25. This indicates that TRT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.25, TRT is in the better half of the industry, outperforming 75.93% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.54
Quick Ratio 4.25
TRT Yearly Current Assets VS Current LiabilitesTRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

1

3. Growth

3.1 Past

TRT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.28%.
TRT shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.82% yearly.
The Revenue has decreased by -6.16% in the past year.
Measured over the past years, TRT shows a small growth in Revenue. The Revenue has been growing by 1.54% on average per year.
EPS 1Y (TTM)-36.28%
EPS 3YN/A
EPS 5Y-9.82%
EPS Q2Q%-1.19%
Revenue 1Y (TTM)-6.16%
Revenue growth 3Y9.24%
Revenue growth 5Y1.54%
Sales Q2Q%-29.35%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TRT Yearly Revenue VS EstimatesTRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
TRT Yearly EPS VS EstimatesTRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 49.23 indicates a quite expensive valuation of TRT.
TRT's Price/Earnings is on the same level as the industry average.
TRT is valuated expensively when we compare the Price/Earnings ratio to 29.98, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 49.23
Fwd PE N/A
TRT Price Earnings VS Forward Price EarningsTRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

99.07% of the companies in the same industry are more expensive than TRT, based on the Enterprise Value to EBITDA ratio.
TRT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. TRT is cheaper than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 30.22
EV/EBITDA 1.35
TRT Per share dataTRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

TRT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TRIO-TECH INTERNATIONAL

NYSEARCA:TRT (3/3/2025, 3:46:02 PM)

6.4

+0.18 (+2.89%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-17 2025-02-17
Earnings (Next)05-12 2025-05-12
Inst Owners16.93%
Inst Owner Change3.15%
Ins Owners26%
Ins Owner Change-0.52%
Market Cap27.20M
Analysts0
Price TargetN/A
Short Float %0.1%
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 49.23
Fwd PE N/A
P/S 0.71
P/FCF 30.22
P/OCF 17.71
P/B 0.85
P/tB 0.85
EV/EBITDA 1.35
EPS(TTM)0.13
EY2.03%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.21
FCFY3.31%
OCF(TTM)0.36
OCFY5.65%
SpS9.07
BVpS7.49
TBVpS7.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.47%
ROE 1.83%
ROCE 1.43%
ROIC 1.03%
ROICexc 2.07%
ROICexgc 2.07%
OM 1.23%
PM (TTM) 1.51%
GM 25.75%
FCFM 2.33%
ROA(3y)3.88%
ROA(5y)2.51%
ROE(3y)5.73%
ROE(5y)3.71%
ROIC(3y)4.2%
ROIC(5y)N/A
ROICexc(3y)7.45%
ROICexc(5y)N/A
ROICexgc(3y)7.45%
ROICexgc(5y)N/A
ROCE(3y)5.9%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y11.52%
ROICexc growth 3YN/A
ROICexc growth 5Y11.52%
OM growth 3YN/A
OM growth 5Y6.23%
PM growth 3YN/A
PM growth 5Y-8.9%
GM growth 3Y2.49%
GM growth 5Y2.07%
F-Score7
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.93
Debt/EBITDA 0.16
Cap/Depr 22.14%
Cap/Sales 1.65%
Interest Coverage 7.18
Cash Conversion 45.91%
Profit Quality 154.11%
Current Ratio 4.54
Quick Ratio 4.25
Altman-Z 4.15
F-Score7
WACC11.44%
ROIC/WACC0.09
Cap/Depr(3y)49.65%
Cap/Depr(5y)43.62%
Cap/Sales(3y)5.01%
Cap/Sales(5y)4.28%
Profit Quality(3y)151.17%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.28%
EPS 3YN/A
EPS 5Y-9.82%
EPS Q2Q%-1.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.16%
Revenue growth 3Y9.24%
Revenue growth 5Y1.54%
Sales Q2Q%-29.35%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-43.44%
EBIT growth 3YN/A
EBIT growth 5Y7.87%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y125%
FCF growth 3Y56.1%
FCF growth 5Y4.6%
OCF growth 1Y-69.64%
OCF growth 3Y15.97%
OCF growth 5Y-10.48%